Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CASP6 | P55212 | 1/20 | 0.48 |
| ▸ | NQO2 | P16083 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30081469 | 1.00 | CYP1A2 (1.00) | CYP1A2ALDH1A1CYP2A6KDM4ELMNA | |
| SCHEMBL31261751 | 1.00 | CYP1A2 (1.00) | CYP1A2ALDH1A1CYP2A6KDM4ELMNA | |
| SCHEMBL29444268 | 0.83 | CYP1A2 (1.00) | CYP1A2ALDH1A1CYP2A6KDM4ELMNA | |
| SCHEMBL161703 | 0.83 | CYP1A2 (1.00) | CYP1A2ALDH1A1CYP2A6KDM4ELMNA | |
| SCHEMBL12017824 | 0.82 | CYP1A2 (0.69) | CYP1A2ALDH1A1CYP2A6KDM4ELMNA | |
| Quinoline SCHEMBL28182317 | 0.82 | ALDH1A1 (0.71) | CYP1A2ALDH1A1CYP2A6POLBNQO2 | |
| SCHEMBL10259445 | 0.81 | CYP1A2 (0.68) | CYP1A2KDM4ELMNAPOLBCASP6 | |
| Iodide SCHEMBL31142554 | 0.81 | CYP1A2 (0.95) | CYP1A2ALDH1A1CYP2A6KDM4ELMNA | |
| SCHEMBL28051566 | 0.80 | CYP1A2 (0.67) | CYP1A2ALDH1A1CYP2A6KDM4ELMNA | |
| SCHEMBL9217980 | 0.79 | CYP1A2 (0.65) | CYP1A2KDM4ELMNAPOLBCASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 373 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250290891-A1 | SYSTEMS AND METHODS FOR POINT-OF-CARE ELECTROCHEMICAL DETECTION OF BIOMARKERS IN LIQUIDS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2025-09-18 | — | — | US | claimed |
| CN-106189235-B | A kind of sulfone polymer composition and the thermoplastic composition being made from it and application | 金发科技股份有限公司 | 2017-10-24 | — | — | CN | claimed |
| CN-106189235-A | A kind of sulfone polymer composition and consisting of thermoplastic composition and application | 金发科技股份有限公司 | 2016-12-07 | — | — | CN | claimed |
| US-7105214-B2 | Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds | XEROX CORPORATION (US) | 2006-09-12 | — | — | US | claimed |
| US-20030124320-A1 | Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds | XEROX CORPORATION | 2003-07-03 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0673782-B1 | Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds | XEROX CORP (US) | 2000-06-14 | — | — | EP | claimed |
| US-5939568-A | Accelerated catalysis of olefinic epoxidations | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-08-17 | — | — | US | claimed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | claimed |
| US-5657064-A | Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds | XEROX CORPORATION (US) | 1997-08-12 | — | — | US | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0673782-A2 | Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-20250290891-A1 | SYSTEMS AND METHODS FOR POINT-OF-CARE ELECTROCHEMICAL DETECTION OF BIOMARKERS IN LIQUIDS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2025-09-18 | — | — | US | disclosed |
| US-4225460-A | Latent Lewis acid catalyst system and process | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1980-09-30 | — | — | US | disclosed |
| US-4224422-A | ADHESIVES; STORAGE STABILITY | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1980-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | CYP1A2 1592/4885ALDH1A1 3874/4885CYP2A6 4027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.